Press Releases Sedana Medical AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 09:30:00 27/06/2024 pm IST			5-day change	1st Jan Change
23.5 ^SEK	-4.86%		-2.89%	+1.47%

29/05	Sedana Medical AB Completes Patient Recruitment for its Clinical Program in the US	CI
22/05	Sedana Medical AB Approves Election of Jens Viebke and Donna Haire as Board Members	CI

Sedana Medical completes patient recruitment for its clinical program in the US	29/05	AQ
Report from Sedana Medical's annual general meeting on 22 May 2024	22/05	AQ
Sedana Medical Q1 - Set to beat conservative sales target	26/04	AQ
Sedana Medical AB's Interim report January-March 2024	25/04	AQ
Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US	25/04	AQ
Notice of Annual General Meeting in Sedana Medical	22/04	AQ
Sedana Medical publishes its Annual Report for 2023	16/04	AQ
Invitation to presentation of Sedana Medical's interim report for the first quarter 2024	05/04	AQ
Sedana Medical Q4 - Likely to beat conservative 2024 sales target	16/02	AQ
Sedana Medical AB's Year-end report 2023	15/02	AQ
Invitation to presentation of Sedana Medical's fourth quarter and year-end report for 2023	25/01	AQ
Sedana Medical files submission for paediatric indication	20/12	AQ
Sedana Medical secures data exclusivity and market protection for Sedaconda[®] (isoflurane) until 2031	22/11	AQ
Key results of Sedana Medical's paediatric study IsoCOMFORT published	16/11	AQ
Sedana Medical Q3 - Accelerated geographical expansion up next	30/23/30	AQ
Sedana Medical AB's Interim report January-September 2023	26/23/26	AQ
Sedana Medical's Nomination Committee established	24/23/24	AQ
The SESAR investigator-initiated trial completes patient enrollment	23/23/23	AQ
Sedana Medical receives market approval in the UK	10/23/10	AQ
Invitation to presentation of Sedana Medical's interim report for the third quarter 2023	05/23/05	AQ

No results for this search